A novel antibiotic free plasmid selection system: Advances in safe and efficient DNA therapy

Biotechnology Journal

Volumn 3, Issue 1, 2008, Pages 83-89

  Mairhofer, Jürgen ^a   Pfaffenzeller, Irene ^a   Merz, David ^a   Grabherr, Reingard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Antibiotic resistance gene; ColE1 origin of replication; Gene therapy; Plasmid addiction; Plasmid selection

Indexed keywords

ANTIBIOTIC RESISTANCE GENE; PLASMID ADDICTION; PLASMID SELECTION;

ANTIBIOTICS; ESCHERICHIA COLI; GENE EXPRESSION; VACCINES;

DNA;

ANTIBIOTIC AGENT; COMPLEMENTARY RNA; DNA VACCINE; REPRESSOR PROTEIN; TRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DNA MODIFICATION; ESCHERICHIA COLI; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENE THERAPY; GENETIC SELECTION; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; SAFETY; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; GENE THERAPY; GENETIC ENGINEERING; PLASMIDS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 38849198564     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700141     Document Type: Article

References (31)

1. Food and Drug Administration, Points to consider on plasmid DNA vaccines for preventive infectious diseases. Docket No. 96N-0400 2006, www.fda.gov/cber/gdlns/plasmid.pdf.
2. World Health Organization, WHO guidelines for assuring the quality of DNA vaccines. Biologicals 1998, 26, 205-212.
3. Murphy, D. B., Epstein, S. L., Guidance for Industry: Guidance for human somatic cell therapy and gene therapy, Food and Drug Administration, Rockville 1998.
4. Smith, H. A., Klinman, D. M., The regulation of DNA vaccines. Curr. Opin. Biotechnol. 2001, 12, 299-203.
5. Cranenburgh, R. M., Hanak, J. A., Williams, S. G., Sherratt, D. J., Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acid Res. 2001, 29, e26.
6. Rozkov, A., Avignone-Rossa, C. A., Ertl, P. F., Jones, P. et al, Fed batch culture with declining specific growth rate for high-yielding production of plasmid containing a gene therapy sequence in Escherichia coli DH1. Enzyme Microb. Technol. 2008, 39, 47-50.
7. Smith, M. A., Bidochka, M. J., Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. Can. J. Microbiol. 1998, 44, 351-356.
8. Williams, S. G., Cranenburgh, R. M., Weiss, A. M., Wrighton, C. J. et al., Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Res. 1996, 26, 2120-2124.
9. Cranenburgh, R. M., Lewis, K. S., Hanak, J. A., Effect of plasmid copy number and lac operator sequence on antibiotic-free plasmid selection by operator-repressor titration in Escherichia coli. J. Mol. Microbiol. Biotechnol. 2004, 7, 197-203.
10. Dryselius, R., Nekhotiaeva, N., Nielsen, P. E., Good, L., Bacterial strain selection using antisense peptide nucleic acids. Biotechniques 2003, 35, 1060-1064.
11. Hägg, P., De Pohl, J. W., Abdulkarim, F., Isaksson, L. A., A host/ plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli. J. Biotechnol. 2006, 111, 17-30.
12. Pfaffenzeller, I., Mairhofer, J., Striedner, G., Bayer, K., Grabherr, R., Using CoIE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system. Biotechnol. J. 2006, 6, 675-681.
13. Cranenburgh, R., Antibiotic free systems for production. Genet. Eng. News 2006, 26, 66.
14. Jechlinger, W., Tabrizi, C. A., Lubitz, W., Mayrhofer, P., Minicircle DNA immobilized in bacterial ghosts: In vivo production of safe non-viral DNA delivery vehicles. J. Mol. Microbiol. Biotechnol. 2004, 8, 222-231.
15. Schakowski, F., Gorschluter, M., Junghans, C., Schroff, M. et al., A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol. Ther. 2001, 3, 793-800.
16. Tomizawa, J., Control of ColE1 plasmid replication: Intermediates in the binding of RNAI and RNAII. J. Mol. Biol. 1990, 212, 683-694.
17. Eguchi, Y., Itoh, T., Tomizawa, J., Antisense RNA. Annu. Rev. Biochem. 1991, 60, 631-652.
18. Yanisch-Perron, C., Vieira, J., Messing, J., Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985, 33, 103-119.
19. Lin-Chao, S., Chen, W. T., Wong, T. T., High copy number of the pUC plasmid result from a Rom/Rop suppressible point mutation in RNA II. Mol. Microbiol. 1992, 6, 3365-3393.
20. Brown, E. D., Vivas, E. I., Walsh, C. T., Kolter, R., MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis is essential in Escherichia coli. J Bacteriol. 1995, 177, 4194-4197.
21. Herring, C. D., Blattner, F. R., Conditional lethal amber mutations in essential Escherichia coli genes. J. Bacteriol. 2004, 186, 2673-2681.
22. Datsenko, K. A., Wanner, B. L., One-step inactivation of chromosomel genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 2000, 97, 6640-6645.
23. Yew, N. S., Zhao, H., Wu, I. H., Song, A. et al., Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 2000, 1, 255-262.
24. Li, S. D., Huang, L., Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther. 2006, 13, 1313-1319.
25. Prazeres, D. M., Ferreira, G. N., Monteiro, G. A., Cooney, C. L. et al., Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol. 1999, 17, 169-174.
26. Rodriguez, E. G., Nonviral DNA vectors for immunization and therapy: design and methods for their obtention. J. Mol. Med. 2004, 82, 500-509.
27. Urthaler, J., Buchinger, W., Necina, R., Industrial scale cGMP purification of pharmaceutical grade plasmid-DNA. Chem. Eng. Technol. 2005, 28, 1406-1420.
28. Urthaler, J., Ascher, C., Wöhrer, C., Necina, R., Automated alkaline lysis for industrial scale cGMP production of pharmaceutical grade plasmid-DNA. J. Biotechnol. 2007, 128: 132-149.
29. Mangan, S., Alon, U., Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. USA 2003, 100, 11980-11985.
30. Yokobayashi, Y., Weiss, H., Arnold, F. H., Directed evolution of genetic circuit. Proc. Natl. Acad. Sci. USA 2002, 99, 16587-16591.
31. Alon, U., An Introduction to Systems Biology: Design Principles of Biological Circuits, Chapman & Hall/CRC Mathematical & Computational Biology, 2006.